*Some Market data delayed by 15 mins.

Biomea Fusion, Inc. Common Stock

Symbol: BMEA (NASDAQ)
0.00 ▼ (-100.00%) -11.500

Company Description:
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $11.5
  • Yesterday High: $12.1
  • Yesterday Low: $11.4401
  • Yesterday Volume: 798.54K
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: Biomea Fusion, Inc. Common Stock
  • Website: https://www.biomeafusion.com
  • Listed Date: 2021-04-16
  • Location: REDWOOD CITY, CA
  • Market Status: Active
  • CIK Number: 0001840439
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $412.73M
  • Round Lot: 100
  • Outstanding Shares: 35.89M
  • Asset Type: CS
RECENT FILINGS FOR BMEA
Filing DateFiling TypeFormat
2024-04-10SC 13GView
2024-04-018-KView
2024-04-018-KView
2024-03-2810-KView
2024-03-078-KView
2024-02-14SC 13G/AView
2024-02-12SC 13G/AView
2024-02-12SC 13G/AView
2024-02-12SC 13G/AView
2024-02-09SC 13G/AView
2024-02-08SC 13GView
2024-01-29SC 13GView
2024-01-184View
2024-01-184View
2024-01-184View
2024-01-184View
2024-01-108-KView
2024-01-05S-8View
2024-01-034View
2023-12-014View
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.